Chris Twelves

Chris Twelves

University of Leeds - Leeds / United Kingdom
Others
AD Scientific Index ID: 1192422
person_outline Chris Twelves's MOST POPULAR ARTICLES
1-) Capecitabine as adjuvant treatment for stage III colon cancerC Twelves, A Wong, MP Nowacki, M Abt, H Burris III, A Carrato, J Cassidy, ...New England Journal of Medicine 352 (26), 2696-2704, 200515542005
2-) Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial resultsJ O’Shaughnessy, D Miles, S Vukelja, V Moiseyenko, JP Ayoub, ...Journal of clinical oncology 20 (12), 2812-2823, 200214102002
3-) Eribulin monotherapy versus treatment of physician\\\'s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyJ Cortes, J O\\\'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ...The Lancet 377 (9769), 914-923, 201113322011
4-) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyE Van Cutsem, C Twelves, J Cassidy, D Allman, E Bajetta, M Boyer, ...Journal of Clinical Oncology 19 (21), 4097-4106, 200113332001
5-) Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...Journal of Clinical Oncology 36 (24), 2465-2472, 201810402018